NURECA / NSE / Medical Equipment & Supplies
Nureca
1Y Price Trend
Key Information
Recommendations
Target High343.6
Target Low200.1
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk51.56
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Nureca Consolidated March 2026 Net Sales at Rs 35.41 crore, up 11.55% Y-o-Y Moneycontrol.com
Nureca Ltd is Rated Strong Sell Markets Mojo
Nureca Ltd Valuation Shifts Signal Heightened Risk Amid Market Downturn Markets Mojo
Nureca reports consolidated net loss of Rs 6.09 crore in the March 2026 quarter Business Standard
Nureca revises capex approval to ₹128 Cr for FY26 scanx.trade
Nureca Q4 FY26: Sharp Loss Reversal Raises Serious Concerns Markets Mojo
Nureca Publishes FY26 Audited Results in Line with Listing Norms TipRanks
Nureca appoints Chander Kant as CFO after Naresh Gupta resigns scanx.trade
© SharekeyX | Rusaka Technologies 2024-2026